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496degree of pulmonary edema and pulmonary ﬁbrosis
with high feasibility and very high agreement over 4
levels of severity. Our results are consistent with
those of a recently published paper by Brattain et al.
(4), which underlines the need for a computerized
diagnostic decision support system based on sono-
graphic video processing to aid nonexpert users.
The added value of our ﬁndings lies in the use of
an artiﬁcial neural network pattern recognition pro-
cedure to create a new decision support system
tool for processing and computer-aided analysis of
LUS images. Moreover, we analyzed B-line videos
derived from pulmonary congestion and pulmonary
ﬁbrosis, with very similar results between the 2
etiologies.
This software could be a robust approach for
developing a portable device for the individualized
and automatic detection of pulmonary interstitial
edema or ﬁbrosis, which could have a high impact
on public health. We are moving toward pervasive
healthcare systems in human-oriented environments.
Because telemedicine is being increasingly used in
many different scenarios for patient monitoring
and specialist consultations (5), the development of
operator-independent, computer-based systems to
support clinical judgment contributes to promoting
radical changes toward a patient-centric healthcare
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Culprit Vessel Vulnerability in Non–ST-
Segment Elevation Acute Coronary SyndromeSeveral studies have demonstrated that multivessel
disease is an independent predictor of coronary
plaque progression and recurrent acute coronary
events (1). Angiographic-based SYNTAX (Synergy
Between PCI With TAXUS and Cardiac Surgery)
score (SS) has consistently been shown to be an
independent predictor of major adverse cardiac
events, mortality, or both at follow-up ranging be-
tween 1 and 5 years (2,3). Several reasons may ac-
count for the increased risk of major adverse cardiac
events in patients with high SS, including a higher
number of obstructive plaques, more complex le-
sions, and a larger necrotic core. The aim of this
study was to investigate the relation between SS
and culprit vessel morphology as evaluated by op-
tical coherence tomography (OCT) in patients with
non–ST-segment elevation acute coronary syndrome
(NSTEACS).
The study group comprised 144 patients with
NSTEACS who underwent percutaneous coronary
intervention (PCI) to treat de novo culprit lesions
with clinically signiﬁcant stenosis in the native cor-
onary artery in whom OCT was performed before
intervention. The culprit lesion was identiﬁed on
the basis of coronary angiography, electrocardiog-
raphy, and transthoracic echocardiography. Non-
culprit plaques were deﬁned as independent plaques
and had to be situated at least 5 mm from the stent
edge in treated or nontreated vessels. A total of 81
nonculprit plaques in 81 patients met these criteria.
The SS was evaluated by 2 core laboratory analysts
(Cardiocore, Yokohama, Japan), who looked together
at the angiograms.
The patients were divided into tertiles according
to the SS at baseline: a low SS group, 48 patients
with an SS of <9 (range 1 to 8); an intermediate SS
group, 47 patients with an SS of $9 to <16 (range 9 to
15); and a high SS group, 49 patients with an SS
of $16 (range 16.0 to 46.5). Intraobserver and inter-
observer variability yielded acceptable concordance
for the tertile of SS (kappa ¼ 0.87 and 0.78, respec-
tively). Angiographic diameter stenosis of the non-
culprit plaques in the high SS group was signiﬁcantly
higher compared with that in the intermediate and
low SS groups (45% vs. 35% vs. 36%; p ¼ 0.02). The
high SS group had a signiﬁcantly lower minimum
ﬁbrous cap thickness (FCT) in the culprit lesion
FIGURE 1 Representative Case of the High SYNTAX Group and the Low SYNTAX Group
(A) Representative case in the high SYNTAX (Synergy Between PCI With TAXUS and Cardiac
Surgery) score (SS) group (SS 23). Thin cap ﬁbroatheroma (TCFA) with a minimum ﬁbrous
cap thickness (FCT) of 57 mm (yellow arrows; A2) and plaque rupture in the culprit lesion
(A3) where shown. (B) Representative case in the low SS group (SS 7). White arrow shows
the culprit lesion. Thick ﬁbrous cap with a minimum FCT of 100 mm (yellow arrows, B2)
was shown.
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497compared with the intermediate SS group and low SS
group (60 [50 to 63] mm vs. 70 [57 to 93] mm vs. 77 [57
to 140] mm; p ¼ 0.001). Moreover, the minimum FCT
in the nonculprit lesion was signiﬁcantly lower in the
high SS group than in the intermediate and low SS
groups (90 [70 to 170] mm vs. 100 [67 to 140] mm vs.
137 [102 to 210] mm; p ¼ 0.03). The frequencies of
lipid-rich plaque (90% vs. 85% vs. 68%; p ¼ 0.02),
thin cap ﬁbroatheroma (73% vs. 40% vs. 40%;
p ¼ 0.001), and plaque rupture in the culprit lesion
(63% vs. 47% vs. 31%; p ¼ 0.007) and of multiple
plaque ruptures in the culprit vessel (24% vs. 9% vs.
2%; p ¼ 0.002) were signiﬁcantly higher in the high SS
group than in the intermediate and low SS groups.
Figures 1A and 1B demonstrate the representative case
in the high SYNTAX group (SS 23) and the low SYN-
TAX group (SS 7).
Our results suggest that patients with high SS
may have heightened plaque vulnerability in culprit
as well as nonculprit lesions. Several studies have
shown that SS can predict the risk of adverse events
in patients with coronary artery disease (2) as well
as those with NSTEACS who undergo PCI. In accor-
dance with the concept that plaque instability is a
pancoronary process, a high SS might reﬂect more
vulnerable plaque morphology in both culprit and
nonculprit lesions. Heightened vulnerability of non-
culprit plaques in patients with high SS might thus
provoke fatal or nonfatal coronary events even after
successful revascularization for culprit lesions. Our
results are supported by the ﬁndings of Genereux
et al. (4), who showed that SS after PCI (residual SS)
was at least as strong a predictor of subsequent
ischemic events as SS calculated before PCI. Their
ﬁndings and our results are considered to highlight
the importance of complete revascularization in pa-
tients with high SS. In the present study, 83% (119
patients) had a low SS (<23) according to the original
SYNTAX trial criteria (3). It is possible that culprit
and nonculprit lesion vulnerability may have been
even greater in intermediate and high SS patients
according to the original cutoff values. Finally, a
limitation of the present study is that to date, there
have been no prospective studies correlating the
OCT ﬁndings that we used to assess plaque vulnera-
bility with future plaque rupture or adverse cardiac
events.Kenichiro Saka, MD
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Assessment: The Road Less TraveledWe read with great interest the recent paper by
Friedman et al. (1). The authors have endeavored to
highlight the importance of early recognition of risk
factors for cardiovascular and cerebrovascular dis-
ease and early management of these risk factors.
However, we would like to highlight a factor worth
considering.
Risk factors are no doubt important in the devel-
opment of subclinical disease; however, we cannot
treat every patient with risk factors, nor can we
perform imaging on everyone with risk factors. This is
just not practical.
However, there is growing evidence (2,3) that
there is a strong correlation between subclinical car-
diac dysfunction and subclinical brain infarcts, for
example, as detected by Russo et al. (4) in the land-
mark CABL (Cardiovascular Abnormalities and Brain
Lesions) trial through speckle tracking echocardiog-
raphy. Therefore, imaging of the heart would be
much more cost-effective in detecting subtle and
pre-clinical changes. Nevertheless, it is an excellent
systematic review that elucidates the importance of
being pre-emptive in the management of any disease
entity, hence reminding us, “get it before it metabo-
lizes you.”Aitzaz Bin Sultan Rai, MD, MSc (oxon)*
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Assessment: The Road Less TraveledWe thank Dr. Rai and colleagues for their interest in
our paper (1). We agree with them on the impor-
tance of these risk factors in the development of
subclinical disease. These risk factors need to be
addressed in accordance with the American Heart
Association/American College of Cardiology guide-
lines to reduce cardiovascular risk (2), and should be
applicable to adults both with and without existing
cardiovascular disease. In our review, we have
gathered evidence from the published studies that
the subjects without symptomatic cardiovascular,
cerebrovascular, or peripheral vascular disease, but
harboring the same risk factors for development of
cardiovascular disease, also experience structural
and functional brain imaging changes with cognitive
consequences. Given that a greater number of per-
sons in our aging population are projected to
develop mild forms of vascular cognitive impair-
ment and cardiovascular disease, it is important,
through continued imaging investigations, to gain a
better understanding of the mechanisms underlying
their mutual development. Such research endeavors
may lead to enhanced early interventions to reverse
or halt their progression and improve clinical out-
comes. We have not suggested that we undertake
brain imaging in every patient harboring a vascular
risk factor (1).Joseph I. Friedman, MD*
Cheuk Y. Tang, PhD
Zahi A. Fayad, PhD
Valentin Fuster, MD
Jagat Narula, MD
*Department of Psychiatry
Department of Neuroscience
Icahn School of Medicine at Mount Sinai
1450 Madison Avenue, Ofﬁce 533
New York, New York 10029
E-mail: Joseph.friedman@mssm.edu
http://dx.doi.org/10.1016/j.jcmg.2014.11.014
R EF E RENCE S
1. Friedman JI, Tang CY, de Haas HJ, et al. Brain imaging changes associated
with risk factors for cardiovascular and cerebrovascular disease in asymp-
tomatic patients. J Am Coll Cardiol Img 2014;7:1039–53.
2. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle
management to reduce cardiovascular risk: a report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol 2014;63:2960–84.
